Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Neurol ; 22(1): 378, 2022 Oct 05.
Article in English | MEDLINE | ID: mdl-36199036

ABSTRACT

BACKGROUND: Acute vestibular syndrome (AVS) is a common clinical syndrome in neurology clinics and emergency department. Canonical standard for AVS diagnosis requires the presence of persistent vertigo for more than 24 h. HINTS (head impulse-nystagmus-test of skew) is an emerging scheme in the diagnosis of AVS. In this prospective study, we evaluated the specificity and sensitivity of HINTS in distinguishing between central and peripheral AVS. METHODS: A cohort of 239 cases with complete clinical record was recruited in the study. All patients completed emergency brain CT examination to exclude hemorrhagic stroke. HINTS examination was conducted to distinguish between central AVS and peripheral AVS, and all patients completed head MRI, BAEP and vestibular function examinations within one week. Patients diagnosed as central AVS were subject to angiography (CTA/MRA/DSA), and patients with peripheral AVS were considered for a 3-month follow-up to correct the initial diagnosis. RESULTS: Patients with central AVS were associated with an elder age, higher incidences of hypertension, atrial fibrillation, family history of stroke and previous history of stroke. Posterior circulation cerebral infarction, vestibular migraine and cerebellitis were the dominant diseases associated with central AVS. The sensitivities of HIT, GE, and TS in the diagnosis of central AVS were 73.5%, 61.2%, and 26.5%, and the specificities were 97.9%, 92.6%, and 93.2% respectively. CONCLUSIONS: The sensitivity of HINTS for central AVS diagnosis is 89.8% and the specificity is 84.2%. HINTS is an easy-to-operate, low-cost, high-sensitivity and specific examination technique, which is practical in neurology outpatient clinics and emergency departments.


Subject(s)
Nystagmus, Pathologic , Stroke , Vestibular Diseases , Acute Disease , Aged , Humans , Prospective Studies , Stroke/complications , Stroke/diagnosis , Stroke/epidemiology , Vertigo/complications , Vestibular Diseases/diagnosis , Vestibular Diseases/etiology
2.
Medicine (Baltimore) ; 100(22): e26242, 2021 Jun 04.
Article in English | MEDLINE | ID: mdl-34087911

ABSTRACT

RATIONALE: A special case of transient oculomotor nerve palsy after cerebral angiography. PATIENT CONCERNS: A 55-year-old man developed oculomotor nerve dysfunction after right radial artery puncture angiography. DIAGNOSES: Cerebral angiography-induced oculomotor nerve palsy. INTERVENTIONS: According to the patient's disease state, intravenous drip of dexamethasone 10 mg/d. OUTCOMES: Magnetic resonance imaging (MRI) showed no abnormalities, and the patient recovered completely after 48 hours of hormone therapy. LESSONS: Transient eye palsy caused by contrast agent encephalopathy is a clinically rare neurological dysfunction caused by adverse effects of contrast agents. Early prevention and correct treatment are critical.


Subject(s)
Cerebral Angiography/adverse effects , Oculomotor Nerve Diseases/etiology , Ophthalmoplegia/etiology , Administration, Intravenous , Aftercare , Contrast Media/adverse effects , Dexamethasone/administration & dosage , Dexamethasone/therapeutic use , Encephalitis/chemically induced , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Oculomotor Nerve Diseases/physiopathology , Ophthalmoplegia/diagnosis , Ophthalmoplegia/drug therapy , Radial Artery/surgery , Treatment Outcome
3.
Neurol Res ; 43(3): 220-224, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33274689

ABSTRACT

Tirofiban can be used to treat patients with acute ischemic stroke (AIS), this study was to evaluate the efficacy and safety of tirofiban combined with heparin in the treatment of mild to moderate AIS. A total of 98 patients with mild to moderate AIS randomly were divided into 2 groups within 48 h: the treatment group treated with tirofiban and, and the control group treated with aspirin + clopidogrel. The treatment group was given the same scheme as the control group after the treatment of tirofiban combined with heparin for 48 h. It was found that, compared with the control group, a significant decreased National Institute of Health stroke scale (NIHSS) was found in 48 h and 14 d, especially to the Barthel index (BI) in the treatment group (P < 0.05). Furthermore, Modified Rankin Scale (MRS, ≤2) in the treatment group was significantly upregulated in 90 d (P < 0.05). However, there were no significant differences in the adverse drug reactions between the two groups. It was indicated that nerve function and long-term prognosis in patients undergoing heparin for mild to moderate AIS were obviously improved than the control group.


Subject(s)
Heparin/therapeutic use , Ischemic Stroke/drug therapy , Platelet Aggregation Inhibitors/therapeutic use , Tirofiban/therapeutic use , Adult , Aged , Aspirin/therapeutic use , Clopidogrel/therapeutic use , Female , Humans , Male , Middle Aged , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...